Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrifast Regulatory News (TRI)

Share Price Information for Trifast (TRI)

Share Price is delayed by 15 minutes
Get Live Data
68.00    0.80 (1.19%)
Bid:
67.40
Ask:
68.00
Spread: 0.60 (0.89%)
Market Cap: £91.78m
TRI Live PriceLast checked at - London Stock Exchange

Intraday Trifast Share Chart

Director/PDMR Shareholding - Replacement

14 Jul 2025 13:44

RNS Number : 9761Q
Trifast PLC
14 July 2025
 

 

Monday, 14 July 2025

 

 

 

 

Trifast plc

(the "Company")

 

Director/PDMR shareholding- Replacement

 

The following amendment(s) has been made to the 'Director/PDMR shareholding' announcement released on 14 July 2025 at 1317hrs under RNS No 9723Q.

Shareholding is 22,185,000 representing 16.3%

All other details remain unchanged.

 

The full amended text is shown below.

 

The Company confirms that certain investment vehicles connected with Nicholas Mills, a Director of the Company, purchased 500,000 Ordinary Shares at a price of 65.5228p on 10 July 2025.

 

Following this purchase, Nicholas Mills and the investment vehicles connected with him are interested in 22,185,000 Ordinary Shares, representing 16.3% of the Company's issued share capital.

 

 

Enquiries:

Trifast plc

Christopher Morgan

Company Secretary

companysecretariat@trifast.com

Tel: +44 (0) 1825 769696

www.trifast.com

 

 

The notification below is made in accordance with the requirements of the EU Market Abuse Regulation.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Rockwood Strategic Plc, PCA to Nicholas Mills

2.

Reason for the notification

a.

Position/status

PCA to PDMR

b.

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Trifast plc

b.

LEI

213800WFIVE6RWK3CR22

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument Identification code

Ordinary shares of 5 pence each 

GB0008883927

b.

Nature of the transaction

Share purchase

c.

Price(s) and volume(s)

 

Price(s)

Volume(s)

65.5228p

500,000

d.

Aggregated information

· Aggregated volume

· Price

 

500,000

65.5228p

e.

Date of the transaction

10 July 2025

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSOURVKUBAAR
Date   Source Headline
14th Sep 20234:48 pmRNSDirectorate Change
29th Aug 20237:00 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSBoard Appointment
3rd Aug 202311:36 amRNSDirector/PDMR Shareholding
19th Jul 20232:31 pmRNSHolding(s) in Company
19th Jul 20237:00 amRNSAR posting - AGM - Sustainability report & TVR
17th Jul 20231:25 pmRNSHolding(s) in Company
11th Jul 20237:00 amRNSAnnual results - 31 March 2023 - Annual Report
9th Jun 20237:00 amRNSNotice of Annual Results
10th May 202311:38 amRNSHolding(s) in Company
4th May 20233:50 pmRNSDirector Declaration
26th Apr 20237:00 amRNSTrading update
4th Apr 20234:45 pmRNSTotal Voting Rights
4th Apr 20234:43 pmRNSBlock listing Interim Review
29th Mar 20234:47 pmRNSHolding(s) in Company
28th Feb 20236:16 pmRNSPDMR Shareholding
28th Feb 20231:38 pmRNSDirector/PDMR Shareholdings
27th Feb 20233:14 pmRNSDirector/PDMR Shareholding
27th Feb 20233:12 pmRNSHolding(s) in Company
22nd Feb 20233:14 pmRNSHolding(s) in Company
21st Feb 20231:24 pmRNSHolding(s) in Company
21st Feb 202310:38 amRNSDirector/PDMR Shareholding
20th Feb 20237:00 amRNSTrading Update and Directorate Change
2nd Feb 20231:23 pmRNSHolding(s) in Company
21st Dec 20224:40 pmRNSSecond Price Monitoring Extn
21st Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20225:27 pmRNSHolding(s) in Company
9th Dec 20224:11 pmRNSHolding(s) in Company - correction
7th Dec 20225:29 pmRNSHolding(s) in Company
24th Nov 202211:20 amRNSDirector/PDMR Shareholding
22nd Nov 20227:00 amRNSMain Board and Senior Appointments
22nd Nov 20227:00 amRNSHalf-yearly Report- six months ended 30.9.22
24th Oct 202210:46 amRNSHolding(s) in Company
24th Oct 202210:45 amRNSHolding(s) in Company
20th Oct 20227:00 amRNSTrading Update & Notice of Half-year results
19th Oct 20226:14 pmRNSHolding(s) in Company
4th Oct 202211:10 amRNSBlock listing Interim Review
7th Sep 20224:41 pmRNSDirector/PDMR Shareholding - LTIP Grant
7th Sep 20224:30 pmRNSResult of AGM
5th Sep 20224:40 pmRNSSecond Price Monitoring Extn
5th Sep 20224:36 pmRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSDirectorate Change
26th Aug 20224:41 pmRNSSecond Price Monitoring Extn
26th Aug 20224:36 pmRNSPrice Monitoring Extension
17th Aug 20229:00 amRNS2022 Annual General Meeting - virtual webcast link
8th Aug 20221:04 pmRNSHolding(s) in Company
3rd Aug 20224:18 pmRNSAvailability of Annual Report & Notice of Meeting
26th Jul 20227:00 amRNSPublication of the 2022 Annual Results
12th Jul 20224:36 pmRNSHolding(s) in Company
4th Jul 20228:00 amRNSNotice of 2022 Annual results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.